{"transactions":[{"id":726275,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-25T22:01:31.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":2324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."}],"balance_after":2324,"derivative":{"underlying":"Common Stock","underlying_shares":2324},"source":{"system":"sec-edgar","filing":"0001104659-26-077862","document":"tm2619022-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465926077862/tm2619022-1_4seq1.xml","form_type":"4"}},{"id":726274,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-25T22:01:31.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":3691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":3691,"derivative":{"exercise_price":107.55,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":3691},"source":{"system":"sec-edgar","filing":"0001104659-26-077862","document":"tm2619022-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465926077862/tm2619022-1_4seq1.xml","form_type":"4"}},{"id":726273,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-25T22:01:31.000Z","date":"2026-06-23","kind":"exercise","planned":false,"acquired":false,"shares":4712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are fully vested. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units are fully vested. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4712},"source":{"system":"sec-edgar","filing":"0001104659-26-077862","document":"tm2619022-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465926077862/tm2619022-1_4seq1.xml","form_type":"4"}},{"id":726272,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-25T22:01:31.000Z","date":"2026-06-23","kind":"exercise","planned":false,"acquired":true,"shares":4712,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":11712,"source":{"system":"sec-edgar","filing":"0001104659-26-077862","document":"tm2619022-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465926077862/tm2619022-1_4seq1.xml","form_type":"4"}},{"id":890412,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-20T21:16:12.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":675000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 19, 2026. The 675,000 shares of common stock underlying the option are scheduled to vest in equal monthly installments through February 19, 2030, subject to the reporting person's continued service with the issuer."}],"balance_after":675000,"derivative":{"exercise_price":10.56,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":675000},"source":{"system":"sec-edgar","filing":"0001193125-26-061391","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000119312526061391/ownership.xml","form_type":"4"}},{"id":1100945,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-26T20:45:20.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":4712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."}],"balance_after":4712,"derivative":{"underlying":"Common Stock","underlying_shares":4712},"source":{"system":"sec-edgar","filing":"0001104659-25-063076","document":"tm2519230-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465925063076/tm2519230-6_4seq1.xml","form_type":"4"}},{"id":1100944,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T20:45:20.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":7037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":7037,"derivative":{"exercise_price":63.66,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":7037},"source":{"system":"sec-edgar","filing":"0001104659-25-063076","document":"tm2519230-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465925063076/tm2519230-6_4seq1.xml","form_type":"4"}},{"id":1103617,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:53:03.000Z","date":"2025-06-18","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units fully vested on June 18, 2025. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units fully vested on June 18, 2025. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-25-061712","document":"tm2518591-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465925061712/tm2518591-5_4seq1.xml","form_type":"4"}},{"id":1103616,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T20:53:03.000Z","date":"2025-06-18","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001104659-25-061712","document":"tm2518591-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465925061712/tm2518591-5_4seq1.xml","form_type":"4"}},{"id":1124544,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Performance Stock Option (right to buy)","published_at":"2025-06-03T20:00:29.000Z","date":"2025-05-31","kind":"grant","planned":false,"acquired":true,"shares":102000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting person was granted a performance-based stock option on February 15, 2024, to purchase 170,000 shares of common stock. The option vested based on the attainment of established performance criteria related to the timing and successful results of the Company's Phase 2b CORAL trial of Haduvio (nalbuphine ER) in patients with chronic cough in idiopathic pulmonary fibrosis, and Phase 2 RIVER trial of Haduvio in patients with refractory chronic cough. On March 10, 2025, the Compensation Committee of the Board of Directors of the Company certified that the performance metrics related to the successful results of the RIVER trial were satisfied, resulting in the vesting of the option as to 54,400 shares of common stock. On May 31, 2025, the Compensation Committee of the Board of Directors of the Company certified that the performance metrics related to the successful results of the CORAL trial were satisfied, resulting in the vesting of the option as to 102,000 shares of common stock."}],"balance_after":156400,"derivative":{"exercise_price":2.38,"exercise_date":"2025-05-31","expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":102000},"source":{"system":"sec-edgar","filing":"0000950170-25-080883","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017025080883/ownership.xml","form_type":"4"}},{"id":1192093,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-25T20:30:04.000Z","date":"2025-03-21","kind":"exercise","planned":false,"acquired":false,"shares":5263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 15, 2015. The 5,263 shares of common stock underlying the option vested as to 25% of the shares on May 15, 2016 and vested as to the remaining 75% of the shares in equal monthly installments thereafter through May 15, 2019."}],"balance_after":0,"derivative":{"exercise_price":1.43,"expiration_date":"2025-05-14","underlying":"Common Stock","underlying_shares":5263},"source":{"system":"sec-edgar","filing":"0000950170-25-044436","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017025044436/ownership.xml","form_type":"4"}},{"id":1192092,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-03-25T20:30:04.000Z","date":"2025-03-21","kind":"sale","planned":false,"acquired":false,"shares":5263,"price":6.5789,"value":34624.7507,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.55 to $6.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":213313,"source":{"system":"sec-edgar","filing":"0000950170-25-044436","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017025044436/ownership.xml","form_type":"4"}},{"id":1192091,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-03-25T20:30:04.000Z","date":"2025-03-21","kind":"exercise","planned":false,"acquired":true,"shares":5263,"price":1.43,"value":7526.09,"ownership":{"direct":true},"balance_after":218576,"source":{"system":"sec-edgar","filing":"0000950170-25-044436","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017025044436/ownership.xml","form_type":"4"}},{"id":1209390,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Performance Stock Option (right to buy)","published_at":"2025-03-12T20:00:10.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":54400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting person was granted a performance-based stock option on February 15, 2024, to purchase 170,000 shares of common stock. The option vests based on the attainment of established performance criteria related to the timing and successful results of the Company's Phase 2b CORAL trial of Haduvio (nalbuphine ER) in patients with chronic cough in idiopathic pulmonary fibrosis, and Phase 2 RIVER trial of Haduvio in patients with refractory chronic cough. On March 10, 2025, the Compensation Committee of the Board of Directors of the Issuer certified that the performance metrics related to the successful results of the RIVER trial were satisfied, resulting in the vesting of the option as to 54,400 shares of common stock. The performance-based stock option remains eligible for vesting with respect to additional shares of common stock underlying the option in the event that performance metrics related to the successful results of the CORAL trial are satisfied."}],"balance_after":54400,"derivative":{"exercise_price":2.38,"exercise_date":"2025-03-10","expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":54400},"source":{"system":"sec-edgar","filing":"0000950170-25-037886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017025037886/ownership.xml","form_type":"4"}},{"id":1255328,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-20T21:00:03.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":811000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 18, 2025. The 811,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 18, 2026 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 18, 2029."}],"balance_after":811000,"derivative":{"exercise_price":4.22,"expiration_date":"2035-02-17","underlying":"Common Stock","underlying_shares":811000},"source":{"system":"sec-edgar","filing":"0000950170-25-024110","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017025024110/ownership.xml","form_type":"4"}},{"id":1402225,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-19T20:30:09.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":false,"shares":7501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":18.99,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":7501},"source":{"system":"sec-edgar","filing":"0001104659-24-101365","document":"tm2424408-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924101365/tm2424408-1_4seq1.xml","form_type":"4"}},{"id":1402224,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-19T20:30:09.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":false,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":21.37,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001104659-24-101365","document":"tm2424408-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924101365/tm2424408-1_4seq1.xml","form_type":"4"}},{"id":1402223,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-19T20:30:09.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":22.93,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-24-101365","document":"tm2424408-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924101365/tm2424408-1_4seq1.xml","form_type":"4"}},{"id":1402222,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T20:30:09.000Z","date":"2024-09-17","kind":"sale","planned":true,"acquired":false,"shares":31751,"price":52.4016,"value":1663803.2016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $52.00 to $53.00. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-24-101365","document":"tm2424408-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924101365/tm2424408-1_4seq1.xml","form_type":"4"}},{"id":1402221,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T20:30:09.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":true,"shares":7501,"price":18.99,"value":142443.99,"ownership":{"direct":true},"balance_after":34751,"source":{"system":"sec-edgar","filing":"0001104659-24-101365","document":"tm2424408-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924101365/tm2424408-1_4seq1.xml","form_type":"4"}},{"id":1402220,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T20:30:09.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":true,"shares":9250,"price":21.37,"value":197672.5,"ownership":{"direct":true},"balance_after":27250,"source":{"system":"sec-edgar","filing":"0001104659-24-101365","document":"tm2424408-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924101365/tm2424408-1_4seq1.xml","form_type":"4"}},{"id":1402219,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T20:30:09.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":22.93,"value":343950.0,"ownership":{"direct":true},"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001104659-24-101365","document":"tm2424408-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924101365/tm2424408-1_4seq1.xml","form_type":"4"}},{"id":1409562,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-11T20:30:12.000Z","date":"2024-09-09","kind":"exercise","planned":true,"acquired":false,"shares":18300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.15,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":18300},"source":{"system":"sec-edgar","filing":"0001104659-24-098941","document":"tm2423816-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924098941/tm2423816-1_4seq1.xml","form_type":"4"}},{"id":1409561,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-11T20:30:12.000Z","date":"2024-09-09","kind":"exercise","planned":true,"acquired":false,"shares":1736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":7501,"derivative":{"exercise_price":18.99,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":1736},"source":{"system":"sec-edgar","filing":"0001104659-24-098941","document":"tm2423816-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924098941/tm2423816-1_4seq1.xml","form_type":"4"}},{"id":1409560,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-11T20:30:12.000Z","date":"2024-09-09","kind":"exercise","planned":true,"acquired":false,"shares":4305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":9250,"derivative":{"exercise_price":21.37,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":4305},"source":{"system":"sec-edgar","filing":"0001104659-24-098941","document":"tm2423816-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924098941/tm2423816-1_4seq1.xml","form_type":"4"}},{"id":1409559,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-11T20:30:12.000Z","date":"2024-09-09","kind":"exercise","planned":true,"acquired":false,"shares":12900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":15000,"derivative":{"exercise_price":22.93,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":12900},"source":{"system":"sec-edgar","filing":"0001104659-24-098941","document":"tm2423816-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924098941/tm2423816-1_4seq1.xml","form_type":"4"}},{"id":1409558,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T20:30:12.000Z","date":"2024-09-09","kind":"sale","planned":true,"acquired":false,"shares":37241,"price":50.4471,"value":1878700.4511,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $50.00 to $50.99. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-24-098941","document":"tm2423816-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924098941/tm2423816-1_4seq1.xml","form_type":"4"}},{"id":1409557,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T20:30:12.000Z","date":"2024-09-09","kind":"exercise","planned":true,"acquired":true,"shares":18300,"price":4.15,"value":75945.0,"ownership":{"direct":true},"balance_after":40241,"source":{"system":"sec-edgar","filing":"0001104659-24-098941","document":"tm2423816-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924098941/tm2423816-1_4seq1.xml","form_type":"4"}},{"id":1409556,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T20:30:12.000Z","date":"2024-09-09","kind":"exercise","planned":true,"acquired":true,"shares":1736,"price":18.99,"value":32966.64,"ownership":{"direct":true},"balance_after":21941,"source":{"system":"sec-edgar","filing":"0001104659-24-098941","document":"tm2423816-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924098941/tm2423816-1_4seq1.xml","form_type":"4"}},{"id":1409555,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T20:30:12.000Z","date":"2024-09-09","kind":"exercise","planned":true,"acquired":true,"shares":4305,"price":21.37,"value":91997.85,"ownership":{"direct":true},"balance_after":20205,"source":{"system":"sec-edgar","filing":"0001104659-24-098941","document":"tm2423816-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924098941/tm2423816-1_4seq1.xml","form_type":"4"}},{"id":1409554,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T20:30:12.000Z","date":"2024-09-09","kind":"exercise","planned":true,"acquired":true,"shares":12900,"price":22.93,"value":295797.0,"ownership":{"direct":true},"balance_after":15900,"source":{"system":"sec-edgar","filing":"0001104659-24-098941","document":"tm2423816-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924098941/tm2423816-1_4seq1.xml","form_type":"4"}},{"id":1411768,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-09T21:00:57.000Z","date":"2024-09-09","kind":"exercise","planned":false,"acquired":false,"shares":1840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on November 25, 2014. The 61,180 shares of common stock underlying the option vested as to 25% of the shares on November 25, 2015 and vested as to the remaining 75% of the shares in equal monthly installments thereafter through November 25, 2018."}],"balance_after":0,"derivative":{"exercise_price":1.43,"expiration_date":"2024-11-24","underlying":"Common Stock","underlying_shares":1840},"source":{"system":"sec-edgar","filing":"0000950170-24-104804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104804/ownership.xml","form_type":"4"}},{"id":1411767,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-09T21:00:57.000Z","date":"2024-09-06","kind":"exercise","planned":false,"acquired":false,"shares":4219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on November 25, 2014. The 61,180 shares of common stock underlying the option vested as to 25% of the shares on November 25, 2015 and vested as to the remaining 75% of the shares in equal monthly installments thereafter through November 25, 2018."}],"balance_after":1840,"derivative":{"exercise_price":1.43,"expiration_date":"2024-11-24","underlying":"Common Stock","underlying_shares":4219},"source":{"system":"sec-edgar","filing":"0000950170-24-104804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104804/ownership.xml","form_type":"4"}},{"id":1411766,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-09T21:00:57.000Z","date":"2024-09-09","kind":"sale","planned":false,"acquired":false,"shares":1840,"price":3.0362,"value":5586.608,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.010 to $3.085 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":213313,"source":{"system":"sec-edgar","filing":"0000950170-24-104804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104804/ownership.xml","form_type":"4"}},{"id":1411765,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-09T21:00:57.000Z","date":"2024-09-09","kind":"exercise","planned":false,"acquired":true,"shares":1840,"price":1.43,"value":2631.2,"ownership":{"direct":true},"balance_after":215153,"source":{"system":"sec-edgar","filing":"0000950170-24-104804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104804/ownership.xml","form_type":"4"}},{"id":1411764,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-09T21:00:57.000Z","date":"2024-09-06","kind":"sale","planned":false,"acquired":false,"shares":4219,"price":3.0302,"value":12784.4138,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 to $3.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":213313,"source":{"system":"sec-edgar","filing":"0000950170-24-104804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104804/ownership.xml","form_type":"4"}},{"id":1411763,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-09T21:00:57.000Z","date":"2024-09-06","kind":"exercise","planned":false,"acquired":true,"shares":4219,"price":1.43,"value":6033.17,"ownership":{"direct":true},"balance_after":217532,"source":{"system":"sec-edgar","filing":"0000950170-24-104804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104804/ownership.xml","form_type":"4"}},{"id":1413671,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T20:54:52.000Z","date":"2024-09-05","kind":"exercise","planned":false,"acquired":false,"shares":40277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on November 25, 2014. The 61,180 shares of common stock underlying the option vested as to 25% of the shares on November 25, 2015 and vested as to the remaining 75% of the shares in equal monthly installments thereafter through November 25, 2018."}],"balance_after":6059,"derivative":{"exercise_price":1.43,"expiration_date":"2024-11-24","underlying":"Common Stock","underlying_shares":40277},"source":{"system":"sec-edgar","filing":"0000950170-24-104061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104061/ownership.xml","form_type":"4"}},{"id":1413670,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T20:54:52.000Z","date":"2024-09-04","kind":"exercise","planned":false,"acquired":false,"shares":10981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on November 25, 2014. The 61,180 shares of common stock underlying the option vested as to 25% of the shares on November 25, 2015 and vested as to the remaining 75% of the shares in equal monthly installments thereafter through November 25, 2018."}],"balance_after":46336,"derivative":{"exercise_price":1.43,"expiration_date":"2024-11-24","underlying":"Common Stock","underlying_shares":10981},"source":{"system":"sec-edgar","filing":"0000950170-24-104061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104061/ownership.xml","form_type":"4"}},{"id":1413669,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T20:54:52.000Z","date":"2024-09-03","kind":"exercise","planned":false,"acquired":false,"shares":3863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on November 25, 2014. The 61,180 shares of common stock underlying the option vested as to 25% of the shares on November 25, 2015 and vested as to the remaining 75% of the shares in equal monthly installments thereafter through November 25, 2018."}],"balance_after":57317,"derivative":{"exercise_price":1.43,"expiration_date":"2024-11-24","underlying":"Common Stock","underlying_shares":3863},"source":{"system":"sec-edgar","filing":"0000950170-24-104061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104061/ownership.xml","form_type":"4"}},{"id":1413668,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-05T20:54:52.000Z","date":"2024-09-05","kind":"sale","planned":false,"acquired":false,"shares":40277,"price":3.1112,"value":125309.8024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.05 to $3.18 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":213313,"source":{"system":"sec-edgar","filing":"0000950170-24-104061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104061/ownership.xml","form_type":"4"}},{"id":1413667,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-05T20:54:52.000Z","date":"2024-09-05","kind":"exercise","planned":false,"acquired":true,"shares":40277,"price":1.43,"value":57596.11,"ownership":{"direct":true},"balance_after":253590,"source":{"system":"sec-edgar","filing":"0000950170-24-104061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104061/ownership.xml","form_type":"4"}},{"id":1413666,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-05T20:54:52.000Z","date":"2024-09-04","kind":"sale","planned":false,"acquired":false,"shares":10981,"price":3.0239,"value":33205.4459,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.02 to $3.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":213313,"source":{"system":"sec-edgar","filing":"0000950170-24-104061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104061/ownership.xml","form_type":"4"}},{"id":1413665,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-05T20:54:52.000Z","date":"2024-09-04","kind":"exercise","planned":false,"acquired":true,"shares":10981,"price":1.43,"value":15702.83,"ownership":{"direct":true},"balance_after":224294,"source":{"system":"sec-edgar","filing":"0000950170-24-104061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104061/ownership.xml","form_type":"4"}},{"id":1413664,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-05T20:54:52.000Z","date":"2024-09-03","kind":"sale","planned":false,"acquired":false,"shares":3863,"price":3.0229,"value":11677.4627,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.01 to $3.03 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":213313,"source":{"system":"sec-edgar","filing":"0000950170-24-104061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104061/ownership.xml","form_type":"4"}},{"id":1413663,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-05T20:54:52.000Z","date":"2024-09-03","kind":"exercise","planned":false,"acquired":true,"shares":3863,"price":1.43,"value":5524.09,"ownership":{"direct":true},"balance_after":217176,"source":{"system":"sec-edgar","filing":"0000950170-24-104061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024104061/ownership.xml","form_type":"4"}},{"id":1420678,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-28T20:30:13.000Z","date":"2024-08-26","kind":"exercise","planned":true,"acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":18300,"derivative":{"exercise_price":4.15,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001104659-24-094009","document":"tm2422915-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924094009/tm2422915-1_4seq1.xml","form_type":"4"}},{"id":1420677,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-28T20:30:13.000Z","date":"2024-08-26","kind":"exercise","planned":true,"acquired":false,"shares":5763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":9237,"derivative":{"exercise_price":18.99,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":5763},"source":{"system":"sec-edgar","filing":"0001104659-24-094009","document":"tm2422915-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924094009/tm2422915-1_4seq1.xml","form_type":"4"}},{"id":1420676,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-28T20:30:13.000Z","date":"2024-08-26","kind":"exercise","planned":true,"acquired":false,"shares":4945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":13555,"derivative":{"exercise_price":21.37,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":4945},"source":{"system":"sec-edgar","filing":"0001104659-24-094009","document":"tm2422915-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924094009/tm2422915-1_4seq1.xml","form_type":"4"}},{"id":1420675,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-28T20:30:13.000Z","date":"2024-08-26","kind":"exercise","planned":true,"acquired":false,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":27900,"derivative":{"exercise_price":22.93,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0001104659-24-094009","document":"tm2422915-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924094009/tm2422915-1_4seq1.xml","form_type":"4"}},{"id":1420674,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-28T20:30:13.000Z","date":"2024-08-26","kind":"sale","planned":true,"acquired":false,"shares":14508,"price":50.0087,"value":725526.2196,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $50.00 to $50.045. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-24-094009","document":"tm2422915-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924094009/tm2422915-1_4seq1.xml","form_type":"4"}},{"id":1420673,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-28T20:30:13.000Z","date":"2024-08-26","kind":"exercise","planned":true,"acquired":true,"shares":1700,"price":4.15,"value":7055.0,"ownership":{"direct":true},"balance_after":17508,"source":{"system":"sec-edgar","filing":"0001104659-24-094009","document":"tm2422915-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924094009/tm2422915-1_4seq1.xml","form_type":"4"}},{"id":1420672,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-28T20:30:13.000Z","date":"2024-08-26","kind":"exercise","planned":true,"acquired":true,"shares":5763,"price":18.99,"value":109439.37,"ownership":{"direct":true},"balance_after":15808,"source":{"system":"sec-edgar","filing":"0001104659-24-094009","document":"tm2422915-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924094009/tm2422915-1_4seq1.xml","form_type":"4"}},{"id":1420671,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-28T20:30:13.000Z","date":"2024-08-26","kind":"exercise","planned":true,"acquired":true,"shares":4945,"price":21.37,"value":105674.65,"ownership":{"direct":true},"balance_after":10045,"source":{"system":"sec-edgar","filing":"0001104659-24-094009","document":"tm2422915-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924094009/tm2422915-1_4seq1.xml","form_type":"4"}},{"id":1420670,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-28T20:30:13.000Z","date":"2024-08-26","kind":"exercise","planned":true,"acquired":true,"shares":2100,"price":22.93,"value":48153.0,"ownership":{"direct":true},"balance_after":5100,"source":{"system":"sec-edgar","filing":"0001104659-24-094009","document":"tm2422915-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924094009/tm2422915-1_4seq1.xml","form_type":"4"}},{"id":1469405,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-25T20:30:21.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-24-074761","document":"tm2418139-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924074761/tm2418139-1_4seq1.xml","form_type":"4"}},{"id":1469404,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-25T20:30:21.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-24-074761","document":"tm2418139-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924074761/tm2418139-1_4seq1.xml","form_type":"4"}},{"id":1472952,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-21T01:39:54.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."}],"balance_after":4000,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-24-073633","document":"tm2417588-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924073633/tm2417588-2_4seq1.xml","form_type":"4"}},{"id":1472951,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T01:39:54.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":41.39,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-24-073633","document":"tm2417588-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465924073633/tm2417588-2_4seq1.xml","form_type":"4"}},{"id":1505249,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-22T20:30:37.000Z","date":"2024-05-20","kind":"exercise","planned":false,"acquired":false,"shares":25037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on July 2, 2014. The 62,804 shares of common stock underlying the option vested as to 25% of the shares on June 11, 2015 and vested as to the remaining 75% of the shares in equal monthly installments thereafter\nthrough June 11, 2018."}],"balance_after":33189,"derivative":{"exercise_price":2.19,"expiration_date":"2024-07-01","underlying":"Common Stock","underlying_shares":25037},"source":{"system":"sec-edgar","filing":"0000950170-24-063531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024063531/ownership.xml","form_type":"4"}},{"id":1505248,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-22T20:30:37.000Z","date":"2024-05-20","kind":"sale","planned":false,"acquired":false,"shares":25037,"price":2.8588,"value":71575.7756,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.82 to $2.955 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":213313,"source":{"system":"sec-edgar","filing":"0000950170-24-063531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024063531/ownership.xml","form_type":"4"}},{"id":1505247,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-22T20:30:37.000Z","date":"2024-05-20","kind":"exercise","planned":false,"acquired":true,"shares":25037,"price":2.19,"value":54831.03,"ownership":{"direct":true},"balance_after":238350,"source":{"system":"sec-edgar","filing":"0000950170-24-063531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024063531/ownership.xml","form_type":"4"}},{"id":1517239,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-14T20:51:46.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":false,"shares":4578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on July 2, 2014. The 62,804 shares of common stock underlying the option vested as to 25% of the shares on June 11, 2015 and vested as to the remaining 75% of the shares in equal monthly installments thereafter\nthrough June 11, 2018."}],"balance_after":58226,"derivative":{"exercise_price":2.19,"expiration_date":"2024-07-01","underlying":"Common Stock","underlying_shares":4578},"source":{"system":"sec-edgar","filing":"0000950170-24-059722","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024059722/ownership.xml","form_type":"4"}},{"id":1517238,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-14T20:51:46.000Z","date":"2024-05-10","kind":"sale","planned":false,"acquired":false,"shares":4578,"price":2.9,"value":13276.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,109 shares purchased through the Issuer's employee stock purchase plan."}],"balance_after":213313,"source":{"system":"sec-edgar","filing":"0000950170-24-059722","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024059722/ownership.xml","form_type":"4"}},{"id":1517237,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-14T20:51:46.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":true,"shares":4578,"price":2.19,"value":10025.82,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,109 shares purchased through the Issuer's employee stock purchase plan."}],"balance_after":217891,"source":{"system":"sec-edgar","filing":"0000950170-24-059722","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024059722/ownership.xml","form_type":"4"}},{"id":1637910,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-16T21:43:02.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":630000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 15, 2024. The 630,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 15, 2025 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 15, 2028."}],"balance_after":630000,"derivative":{"exercise_price":2.38,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":630000},"source":{"system":"sec-edgar","filing":"0000950170-24-016462","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000095017024016462/ownership.xml","form_type":"4"}},{"id":1845035,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-23T20:31:12.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-23-074293","document":"tm2319485-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465923074293/tm2319485-4_4seq1.xml","form_type":"4"}},{"id":1845034,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:31:12.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":18.47,"expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-23-074293","document":"tm2319485-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465923074293/tm2319485-4_4seq1.xml","form_type":"4"}},{"id":2010664,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-16T22:13:57.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 16, 2023. The 375,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 16, 2024 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 16, 2027."}],"balance_after":375000,"derivative":{"exercise_price":2.67,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001209191-23-010152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000120919123010152/doc4.xml","form_type":"4"}},{"id":2155420,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Performance Stock Options (right to buy)","published_at":"2022-09-19T20:26:42.000Z","date":"2022-09-19","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting person was granted a performance-based stock option on February 17, 2021, to purchase 160,000 shares of common stock. The option vests based on the attainment of established performance criteria related to the timing and successful results of the Company's Phase 2b/3 PRISM trial of Haduvio (nalbuphine ER) for the treatment of prurigo nodularis, and Phase 2 CANAL trial of Haduvio for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis. On September 19, 2022, the Compensation Committee of the Board of Directors of the Issuer certified that the performance metrics related to the successful results of the CANAL trial were satisfied, resulting in the vesting of the option as to the 32,000 shares of common stock."}],"balance_after":160000,"derivative":{"exercise_price":3.21,"exercise_date":"2022-09-19","expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001209191-22-050521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000120919122050521/doc4.xml","form_type":"4"}},{"id":2216907,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Performance Stock Options (right to buy)","published_at":"2022-07-01T20:47:30.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":128000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting person was granted a performance-based stock option on February 17, 2021, to purchase 160,000 shares of common stock. The option vests based on the attainment of established performance criteria related to the timing and successful results of the Company's Phase 2b/3 PRISM trial of Haduvio (nalbuphine ER) for the treatment of prurigo nodularis, and Phase 2 CANAL trial of Haduvio for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis. On June 29, 2022, the Compensation Committee of the Board of Directors of the Issuer certified that certain performance metrics related to the successful results of the PRISM trial were satisfied, resulting in the vesting of the option as to 128,000 shares of common stock. The performance-based option remains eligible for vesting with respect to the remaining shares of common stock underlying the option in the event that additional performance metrics related to the successful results of the CANAL trial are satisfied."}],"balance_after":128000,"derivative":{"exercise_price":3.21,"exercise_date":"2022-06-29","expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":128000},"source":{"system":"sec-edgar","filing":"0001209191-22-040284","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000120919122040284/doc4.xml","form_type":"4"}},{"id":2216906,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T20:41:27.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 14, 2022. The 275,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 14, 2023 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 14, 2026."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This amendment to the Form 4 originally filed for the reporting person on February 15, 2022 is being filed solely to attach the power of attorney exhibit that was inadvertently excluded from the original filing."}],"balance_after":275000,"derivative":{"exercise_price":0.5073,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001209191-22-040268","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000120919122040268/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-15"}},{"id":2235676,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T20:08:32.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 8, 2023 or (ii) the date of the Issuer's next annual meeting of the stockholders."}],"balance_after":20000,"derivative":{"exercise_price":4.15,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-070116","document":"tm2218129-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465922070116/tm2218129-3_4seq1.xml","form_type":"4"}},{"id":2394143,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-15T21:00:11.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 14, 2022. The 275,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 14, 2023 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 14, 2026."}],"balance_after":275000,"derivative":{"exercise_price":0.5073,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001209191-22-009733","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000120919122009733/doc4.xml","form_type":"4"}},{"id":2671626,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T20:06:00.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders."}],"balance_after":15000,"derivative":{"exercise_price":18.99,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-080103","document":"tm2119501-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465921080103/tm2119501-3_4seq1.xml","form_type":"4"}},{"id":2845783,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-19T21:15:39.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 17, 2021. The 160,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 17, 2022 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 17, 2025."}],"balance_after":160000,"derivative":{"exercise_price":3.21,"expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0000899243-21-007380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000089924321007380/doc4.xml","form_type":"4"}},{"id":3105229,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T21:26:05.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) 1 year from the date of grant or (ii) the date of the Issuer's next annual meeting of the stockholders."}],"balance_after":18500,"derivative":{"exercise_price":21.37,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001104659-20-074729","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465920074729/a4.xml","form_type":"4"}},{"id":3266416,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-18T21:22:51.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 13, 2020. The 200,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 13, 2021 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 13, 2024."}],"balance_after":200000,"derivative":{"exercise_price":5.5,"expiration_date":"2030-02-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-20-004876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000089924320004876/doc4.xml","form_type":"4"}},{"id":3481087,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-21T20:15:22.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the options will vest on each one-year anniversary of the grant date, with the first one-third vesting on June 19, 2020."}],"balance_after":30000,"derivative":{"exercise_price":22.93,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-19-037021","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000110465919037021/a4.xml","form_type":"4"}},{"id":3500287,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-05T21:07:45.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":310000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 3, 2019. The 310,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on June 3, 2020 and as to the remaining 75% of the shares in equal monthly installments thereafter through June 3, 2023."}],"balance_after":310000,"derivative":{"exercise_price":10.12,"expiration_date":"2029-06-02","underlying":"Common Stock","underlying_shares":310000},"source":{"system":"sec-edgar","filing":"0000899243-19-015605","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000089924319015605/doc4.xml","form_type":"4"}},{"id":3529535,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Series C Preferred Stock","published_at":"2019-05-13T21:01:49.000Z","date":"2019-05-09","kind":"exercise","acquired":false,"shares":23947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2796},"source":{"system":"sec-edgar","filing":"0000899243-19-013256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000089924319013256/doc4.xml","form_type":"4"}},{"id":3529534,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Series A Preferred Stock","published_at":"2019-05-13T21:01:49.000Z","date":"2019-05-09","kind":"exercise","acquired":false,"shares":109015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 9, 2019, the Series A Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 9, 2019, the Series A Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 9, 2019, the Series A Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15552},"source":{"system":"sec-edgar","filing":"0000899243-19-013256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000089924319013256/doc4.xml","form_type":"4"}},{"id":3529533,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-05-13T21:01:49.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":11250,"price":10,"value":112500.0,"ownership":{"direct":true},"balance_after":206204,"source":{"system":"sec-edgar","filing":"0000899243-19-013256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000089924319013256/doc4.xml","form_type":"4"}},{"id":3529532,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-05-13T21:01:49.000Z","date":"2019-05-09","kind":"exercise","acquired":true,"shares":18348,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 9, 2019, the Series A Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":194954,"source":{"system":"sec-edgar","filing":"0000899243-19-013256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229245/000089924319013256/doc4.xml","form_type":"4"}},{"id":3844026,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-15T16:28:12.000Z","date":"2018-08-14","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":11.5,"value":172500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") among Catalent Pharma Solutions, Inc., Catalent Boston, Inc. and Juniper Pharmaceuticals Inc. (the \"Issuer\") dated as of July 2, 2018.  At the effective time of the merger (the \"Effective Time\") as contemplated in the Merger Agreement, each share of outstanding Issuer common stock (other than appraisal shares and certain other shares), and each outstanding and unexercised Issuer stock option (whether vested or unvested) and each outstanding unvested restricted stock unit, immediately prior to the Effective Time were cancelled in exchange for $11.50 per share, net in cash, without interest, less any applicable taxes and applicable exercise price for the stock option (the \"Offer Price\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 15,000 restricted stock units that did not vest prior to the Effective Time of the merger.  Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unvested 15,000 restricted stock units was cancelled in exchange for the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-046802","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118046802/doc4.xml","form_type":"4"}},{"id":4213103,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":35350,"kind":"person","name":"GOOD JENNIFER L","position":1,"cik":"0001229245","reported_name":"GOOD JENNIFER L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2017-09-11T16:27:44.000Z","date":"2017-09-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock unit award shall vest ratably in three equal annual installments, with the first annual installment vesting on the one year anniversary of September 7, 2017 date."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-17-052228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919117052228/doc4.xml","form_type":"4"}}]}